G A Piazza - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

G A Piazza

Showing results (21-30 of 27) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 27 results.

Carcinogenesis|September 23, 1998

Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone)A M Malkinson, K M Koski, L D Dwyer-Nield, et al.

Oncogene|January 31, 2012

Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAsX Li, L Gao, Q Cui, et al.

Biochemical Pharmacology|September 14, 1999

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell linesJ T Lim, G A Piazza, E K Han, et al.

Cancer Research|May 19, 2001

Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesisG A Piazza, W J Thompson, R Pamukcu, et al.

Gastroenterology|December 12, 1997

A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytesN Arber, E K Han, A Sgambato, et al.

Cancer Research|July 15, 1997

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levelsG A Piazza, D S Alberts, L J Hixson, et al.

Oncogene|April 8, 2014

Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activityN Li, K Lee, Y Xi, et al.

Pageof 3

Search research articles

Showing results (21-30 of 27) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 27 results.

Carcinogenesis|September 23, 1998

Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone)A M Malkinson, K M Koski, L D Dwyer-Nield, et al.

Oncogene|January 31, 2012

Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAsX Li, L Gao, Q Cui, et al.

Biochemical Pharmacology|September 14, 1999

Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell linesJ T Lim, G A Piazza, E K Han, et al.

Cancer Research|May 19, 2001

Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesisG A Piazza, W J Thompson, R Pamukcu, et al.

Gastroenterology|December 12, 1997

A K-ras oncogene increases resistance to sulindac-induced apoptosis in rat enterocytesN Arber, E K Han, A Sgambato, et al.

Cancer Research|July 15, 1997

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levelsG A Piazza, D S Alberts, L J Hixson, et al.

Oncogene|April 8, 2014

Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activityN Li, K Lee, Y Xi, et al.

Pageof 3